The Vif and Vpr Accessory Proteins Independently Cause HIV-1-induced T Cell Cytopathicity and Cell Cycle Arrest

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2006 Feb 24

PMID 16492778

Citations 77

Authors

Keiko Sakai

Joseph Dimas

Michael J Lenardo

Affiliations

Soon will be listed here.

Abstract

HIV type I (HIV-1) can cause G(2) cell cycle arrest and death of CD4(+) T lymphocytes in vitro and inexorable depletion of these cells in vivo. However, the molecular mechanism of viral cytopathicity has not been satisfactorily elucidated. Previously, we showed that HIV-1 kills T cells by a necrotic form of cell death that requires high level expression of an integrated provirus but not the env or nef genes. To determine which viral protein(s) are required for cell death, we systematically mutated, alone and in combination, the ORFs of the NL4-3 strain of HIV-1. We found that the elimination of the viral functions encoded by gag-pol and vpu, tat, and rev did not mitigate cytopathicity. However, elimination of the vif and vpr accessory genes together, but not individually, renders the virus incapable of causing cell death and G(2) cell cycle blockade. We thus identify vif and vpr as necessary for T cell cytopathic effects induced by HIV-1. These findings may provide an important insight into the molecular mechanism of viral pathogenesis in AIDS.

Citing Articles

Leong S, Nasser H, Ikeda T Int J Mol Sci. 2025; 26(4).

PMID: 40004025 PMC: 11855278. DOI: 10.3390/ijms26041561.

BACH2-driven tissue resident memory programs promote HIV-1 persistence.

Wei Y, Ma H, Wong M, Papasavvas E, Konnikova L, Tebas P bioRxiv. 2025; .

PMID: 39763845 PMC: 11702684. DOI: 10.1101/2024.12.16.628794.

Central Memory CD4 T Cells from Persons with HIV Accumulate DNA Content Defects During Proliferative Response.

Romero-Rodriguez D, Romero-Rodriguez J, Cervantes-Mejia F, Olvera-Garcia G, Perez-Patrigeon S, Murakami-Ogasawara A AIDS Res Hum Retroviruses. 2024; 41(1):37-42.

PMID: 39466061 PMC: 11839537. DOI: 10.1089/aid.2024.0062.

HIV-1 Vif disrupts phosphatase feedback regulation at the kinetochore, leading to a pronounced pseudo-metaphase arrest.

Ghone D, Evans 3rd E, Bandini M, Stephenson K, Sherer N, Suzuki A bioRxiv. 2024; .

PMID: 39131328 PMC: 11312601. DOI: 10.1101/2024.07.30.605839.

Structural insights into PPP2R5A degradation by HIV-1 Vif.

Hu Y, Delviks-Frankenberry K, Wu C, Arizaga F, Pathak V, Xiong Y Nat Struct Mol Biol. 2024; 31(10):1492-1501.

PMID: 38789685 DOI: 10.1038/s41594-024-01314-6.

References

Liu H, Wu X, Newman M, Shaw G, Hahn B, Kappes J . The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J Virol. 1995; 69(12):7630-8. PMC: 189703. DOI: 10.1128/JVI.69.12.7630-7638.1995. View

Jowett J, Planelles V, Poon B, Shah N, Chen M, Chen I . The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J Virol. 1995; 69(10):6304-13. PMC: 189529. DOI: 10.1128/JVI.69.10.6304-6313.1995. View

Perelson A, Neumann A, Markowitz M, Leonard J, Ho D . HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996; 271(5255):1582-6. DOI: 10.1126/science.271.5255.1582. View

Cao J, Park I, Cooper A, Sodroski J . Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J Virol. 1996; 70(3):1340-54. PMC: 189953. DOI: 10.1128/JVI.70.3.1340-1354.1996. View

Emerman M . HIV-1, Vpr and the cell cycle. Curr Biol. 1996; 6(9):1096-103. DOI: 10.1016/s0960-9822(02)00676-0. View

Zhang H, Pomerantz R, Dornadula G, Sun Y . Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process. J Virol. 2000; 74(18):8252-61. PMC: 116333. DOI: 10.1128/jvi.74.18.8252-8261.2000. View

Fukumori T, Akari H, Yoshida A, Fujita M, Koyama A, Kagawa S . Regulation of cell cycle and apoptosis by human immunodeficiency virus type 1 Vpr. Microbes Infect. 2000; 2(9):1011-7. DOI: 10.1016/s1286-4579(00)01255-7. View

Nishizawa M, Kamata M, Mojin T, Nakai Y, Aida Y . Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle. Virology. 2000; 276(1):16-26. DOI: 10.1006/viro.2000.0534. View

Zhu Y, Gelbard H, Roshal M, Pursell S, Jamieson B, Planelles V . Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J Virol. 2001; 75(8):3791-801. PMC: 114870. DOI: 10.1128/JVI.75.8.3791-3801.2001. View

10.

Roshal M, Zhu Y, Planelles V . Apoptosis in AIDS. Apoptosis. 2001; 6(1-2):103-16. DOI: 10.1023/a:1009636530839. View

11.

Selliah N, Finkel T . HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells. Virology. 2001; 286(2):412-21. DOI: 10.1006/viro.2001.0994. View

12.

Akari H, Bour S, Kao S, Adachi A, Strebel K . The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors. J Exp Med. 2001; 194(9):1299-311. PMC: 2195969. DOI: 10.1084/jem.194.9.1299. View

13.

Goto H, Yasui Y, Nigg E, Inagaki M . Aurora-B phosphorylates Histone H3 at serine28 with regard to the mitotic chromosome condensation. Genes Cells. 2002; 7(1):11-7. DOI: 10.1046/j.1356-9597.2001.00498.x. View

14.

Lenardo M, Angleman S, Bounkeua V, Dimas J, Duvall M, Graubard M . Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J Virol. 2002; 76(10):5082-93. PMC: 136142. DOI: 10.1128/jvi.76.10.5082-5093.2002. View

15.

Bolton D, Park E, Lehnhoff L, Hornung F, Lenardo M . Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis. J Virol. 2002; 76(10):5094-107. PMC: 136143. DOI: 10.1128/jvi.76.10.5094-5107.2002. View

16.

Somasundaran M, Sharkey M, Brichacek B, Luzuriaga K, Emerman M, Sullivan J . Evidence for a cytopathogenicity determinant in HIV-1 Vpr. Proc Natl Acad Sci U S A. 2002; 99(14):9503-8. PMC: 123170. DOI: 10.1073/pnas.142313699. View

17.

Sheehy A, Gaddis N, Choi J, Malim M . Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002; 418(6898):646-50. DOI: 10.1038/nature00939. View

18.

Gallo R . Human retroviruses after 20 years: a perspective from the past and prospects for their future control. Immunol Rev. 2002; 185:236-65. DOI: 10.1034/j.1600-065x.2002.18520.x. View

19.

Douek D, Picker L, Koup R . T cell dynamics in HIV-1 infection. Annu Rev Immunol. 2003; 21:265-304. DOI: 10.1146/annurev.immunol.21.120601.141053. View

20.

Lum J, Cohen O, Nie Z, Weaver J, Gomez T, Yao X . Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest. 2003; 111(10):1547-54. PMC: 155040. DOI: 10.1172/JCI16233. View